According to TipRanks.com, Lieberman is a 3-star analyst with an average return of 2.4% and a 55.1% success rate. Lieberman covers the Consumer Goods sector, focusing on stocks such as International Flavors & Fragrances, Coca-Cola Europacific Partners, and The Estée Lauder Companies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Keurig Dr Pepper with a $42.29 average price target, representing an 11.3% upside. In a report issued on April 27, RBC Capital also maintained a Buy rating on the stock with a $43.00 price target.
The company has a one-year high of $39.35 and a one-year low of $32.44. Currently, Keurig Dr Pepper has an average volume of 6.16M.
Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of KDP in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Massachusetts-based Keurig Dr Pepper, Inc. operates as a non-alcoholic beverage company in the US and internationally. It operates through four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.
Read More on KDP:
- Church & Dwight (CHD) Gets a Sell Rating from Barclays
- Barclays Keeps a Buy Rating on Automatic Data Processing (ADP)
- Analysts Conflicted on These Industrial Goods Names: NOV (NOV) and Regal Rexnord (RRX)
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol Myers (BMY) and Eli Lilly & Co (LLY)
- Analysts Offer Insights on Financial Companies: Arch Capital Group (ACGL), First American Financial (FAF) and Kimco Realty (KIM)